Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 204
Filtrar
2.
Clin Exp Dermatol ; 37(7): 759-61, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22548453

RESUMO

Pagetoid reticulosis or Woringer-Kolopp disease (WKD) is a rare variant of mycosis fungoides, consisting of localized patches or plaques containing intraepidermal proliferations of neoplastic T cells in a pagetoid distribution (similar to that of the adenocarcinomatous cells found in Paget disease of the nipple), which typically affects middle-aged and elderly men. We report a trial of photodynamic therapy (PDT) with topical aminolaevulinic acid (ALA), carried out on a 10-year-old boy with a solitary lesion of WKD on his foot, to avoid the long-term problems associated with the typical treatments for WKD of surgery and/or local irradiation. The plaque progressively flattened during treatment, and after nine PDT sessions over 13 months, the patient was clinically free of disease. PDT may be a viable alternative to surgery and local irradiation for localized cutaneous T-cell lymphoma, including WKD, especially in younger patients.


Assuntos
Ácido Aminolevulínico/uso terapêutico , Dermatoses do Pé/tratamento farmacológico , Reticulose Pagetoide/tratamento farmacológico , Fotoquimioterapia/métodos , Fármacos Fotossensibilizantes/uso terapêutico , Criança , Humanos , Masculino , Resultado do Tratamento
3.
Cell Mol Life Sci ; 66(9): 1493-506, 2009 May.
Artigo em Inglês | MEDLINE | ID: mdl-19153661

RESUMO

The major differentiated function of melanocytes is the synthesis of melanin, a pigmented heteropolymer that is synthesized in specialized cellular organelles termed melanosomes. Mature melanosomes are transferred to neighboring keratinocytes and are arranged in a supranuclear cap, protecting the DNA against incident ultraviolet light (UV) irradiation. The synthesis and distribution of melanin in the epidermis involves several steps: transcription of melanogenic proteins, melanosome biogenesis, sorting of melanogenic proteins into the melanosomes, transport of melanosomes to the tips of melanocyte dendrites and finally transfer into keratinocytes. These events are tightly regulated by a variety of paracrine and autocrine factors in response to endogenous and exogenous stimuli, principally UV irradiation.


Assuntos
Melaninas/biossíntese , Melanócitos/metabolismo , Melanossomas/metabolismo , Dano ao DNA , Humanos , Queratinócitos/metabolismo , Queratinócitos/efeitos da radiação , Melaninas/química , Melanócitos/enzimologia , Melanócitos/efeitos da radiação , Melanossomas/enzimologia , Melanossomas/efeitos da radiação , Modelos Biológicos , Comunicação Parácrina/fisiologia , Transdução de Sinais , Proteína Supressora de Tumor p53/fisiologia , Raios Ultravioleta
4.
Skin Therapy Lett ; 13(5): 1-5, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18648712

RESUMO

Ultraviolet (UV) radiation is a carcinogen that also compromises skin appearance and function. Since the UV action spectra for DNA damage, skin cancer, and vitamin D photosynthesis are identical, and vitamin D is readily available from oral supplements, why has sun protection become controversial? First, the media and, apparently, some researchers are hungry for a new message. They have also drawn attention to the emerging evidence of possible vitamin D benefits other than for bone health. Second, the controversy is fueled by a powerful special interest group: the tanning industry. This industry does not target the frail elderly or inner-city ethnic minorities, which are the groups at greatest risk of vitamin D deficiency, but rather fair-skinned teenagers and young adults, who are at highest risk of UV photodamage. Third, evolution does not keep pace with civilization. When nature gave humans the appealing capacity for cutaneous vitamin D photosynthesis, life expectancy was less than 40 years of age; long-term photodamage was not a concern, and vitamin D deficiency, with its resulting skeletal abnormalities (rickets), was likely to be fatal in early life. This article briefly reviews the pseudo-controversy , as well as the data supporting a revision of the recommendations for vitamin D supplementation. It concludes with a suggested message for patients, many of whom are understandably confused by recent media coverage of the topic.


Assuntos
Suplementos Nutricionais , Protetores Solares , Raios Ultravioleta/efeitos adversos , Deficiência de Vitamina D/prevenção & controle , Vitamina D/biossíntese , Dano ao DNA , Humanos , Neoplasias/etiologia , Neoplasias/prevenção & controle , Risco , Pele/metabolismo , Pele/efeitos da radiação
5.
Br J Dermatol ; 157(5): 874-87, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17711532

RESUMO

Photoageing is the superposition of chronic ultraviolet (UV)-induced damage on intrinsic ageing and accounts for most age-associated changes in skin appearance. It is triggered by receptor-initiated signalling, mitochondrial damage, protein oxidation and telomere-based DNA damage responses. Photodamaged skin displays variable epidermal thickness, dermal elastosis, decreased/fragmented collagen, increased matrix-degrading metalloproteinases, inflammatory infiltrates and vessel ectasia. The development of cosmetically pleasing sunscreens that protect against both UVA and UVB irradiation as well as products such as tretinoin that antagonize the UV signalling pathways leading to photoageing are major steps forward in preventing and reversing photoageing. Improved understanding of the skin's innate UV protective mechanisms has also given rise to several novel treatment concepts that promise to revolutionize this field within the coming decade. Such advances should not only allow for the improved appearance of skin in middle age and beyond, but also greatly reduce the accompanying burden of skin cancer.


Assuntos
Envelhecimento da Pele , Dermatopatias , Antioxidantes/uso terapêutico , Dano ao DNA/efeitos dos fármacos , Humanos , Retinoides/uso terapêutico , Envelhecimento da Pele/fisiologia , Envelhecimento da Pele/efeitos da radiação , Dermatopatias/fisiopatologia , Dermatopatias/prevenção & controle , Dermatopatias/terapia , Protetores Solares/uso terapêutico , Raios Ultravioleta/efeitos adversos
6.
Neuropathol Appl Neurobiol ; 33(5): 533-43, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17596181

RESUMO

The current study determined the ability of a p75(NTR) antagonistic cyclic peptide to rescue cells from beta amyloid (Abeta) (1-40)-induced death. p75(NTR)-, p140(trkA)-NIH-3T3 cells or E17 foetal rat cortical neurones were incubated with 125I-NGF or 125I-Abeta (1-40) and increasing concentrations of the cyclic peptide (CATDIKGAEC). Peptide ability to displace 125I-NGF or 125I-Abeta (1-40) binding was determined. Duplicate cultures were preincubated with CATDIKGAEC (250 nM) or diluent and then stimulated with Abeta (1-40). Peptide ability to displace Abeta (1-40) binding, interfere with Abeta (1-40)-induced signalling and rescue cells from Abeta-mediated toxicity was determined by immunoprecipitation and autoradiography, Northern blotting, JNK activation, MTT and trypan blue assays. The peptide inhibited NGF and Abeta (1-40) binding to p75(NTR), but not to p140(trkA). Abeta (1-40) induced c-jun transcription (57.3% +/- 0.07%) in diluent-treated p75(NTR)-cells, but not in cells preincubated with the cyclic peptide. Also, at 250 nM, the peptide reduced Abeta (1-40)-induced phosphorylation of JNK by 71.8% +/- 0.03% and protected neurones against Abeta-induced toxicity as determined by: trypan blue exclusion assay (53% +/- 11% trypan blue-positive cells in diluent pretreated cultures vs. 28% +/- 5% in cyclic peptide-pretreated cultures); MTT assay (0.09 +/-0.03 units in diluent-pretreated cells vs. 0.12 +/- 0.004 units in cyclic peptide-pretreated cells); and visualization of representative microscopic fields. Our data suggest that a cyclic peptide homologous to amino acids 28-36 of NGF known to mediate binding to p75(NTR) can interfere with Abeta (1-40) signalling and rescue neurones from Abeta (1-40)-induced toxicity.


Assuntos
Morte Celular/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Fármacos Neuroprotetores/farmacologia , Peptídeos Cíclicos/farmacologia , Receptores de Fator de Crescimento Neural/antagonistas & inibidores , Peptídeos beta-Amiloides/efeitos dos fármacos , Peptídeos beta-Amiloides/metabolismo , Animais , Autorradiografia , Northern Blotting , Linhagem Celular , Humanos , Imunoprecipitação , MAP Quinase Quinase 4/efeitos dos fármacos , MAP Quinase Quinase 4/metabolismo , Fator de Crescimento Neural/antagonistas & inibidores , Fator de Crescimento Neural/química , Proteínas do Tecido Nervoso , Fármacos Neuroprotetores/química , Fragmentos de Peptídeos/efeitos dos fármacos , Fragmentos de Peptídeos/metabolismo , Peptídeos Cíclicos/química , Ratos , Receptor trkA/efeitos dos fármacos , Receptor trkA/metabolismo , Receptores de Fatores de Crescimento
8.
FASEB J ; 18(11): 1252-4, 2004 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15208259

RESUMO

In this study, we investigated the effects of estradiol on the proliferation of neonatal keratinocytes, the expression of estrogen receptor isoforms, and the signaling mechanisms by which estradiol mediates cell growth. We demonstrate that estradiol binds neonatal keratinocytes with high affinity (Kd=5.2nM) and limited capacity (Bmax of 14.2fmol/mg of protein), confirming the presence of estrogen binding sites. Using specific antibodies, we demonstrate that keratinocytes express both estrogen receptor (ER)-alpha and ER-beta. At physiological concentrations, estradiol up-regulates the level of ER-alpha receptors in keratinocytes and induces keratinocyte proliferation. The proliferative effect of estradiol requires the availability of functional estrogen receptors, as it is abrogated by anti-estrogen administration. Estradiol effect on keratinocyte proliferation is most likely mediated in part by activation of a nongenomic, membrane-associated, signaling pathway involving activation of the extracellular signal regulated kinases 1 and 2 and in part by the genomic signaling pathway through activation of nuclear receptors.


Assuntos
Estradiol/farmacologia , Receptor alfa de Estrogênio/efeitos dos fármacos , Queratinócitos/efeitos dos fármacos , Divisão Celular/efeitos dos fármacos , Células Cultivadas/citologia , Células Cultivadas/efeitos dos fármacos , Células Cultivadas/metabolismo , Ciclina D1/biossíntese , Receptor alfa de Estrogênio/fisiologia , Receptor beta de Estrogênio/análise , Receptor beta de Estrogênio/efeitos dos fármacos , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Regulação da Expressão Gênica/efeitos dos fármacos , Genes bcl-1/efeitos dos fármacos , Genes fos/efeitos dos fármacos , Genes jun/efeitos dos fármacos , Humanos , Recém-Nascido , Queratinócitos/citologia , Queratinócitos/metabolismo , Masculino , Pênis , Ligação Proteica , Proteínas Proto-Oncogênicas c-jun/biossíntese , Transdução de Sinais/efeitos dos fármacos
9.
Micron ; 35(3): 155-9, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15036269

RESUMO

Recent work has substantially elucidated the mechanisms of skin aging and photoaging. In particular, a central role for telomere-based signaling can be inferred. Intrinsic aging is largely controlled by progressive telomere shortening, compounded by low grade oxidative damage to telomeres and other cellular constituents, the consequence of aerobic cellular metabolism. In sun exposed skin, UV irradiation also damages DNA and accelerates telomere shortening. Aging and photodamage appear to share a common final pathway that involves signaling through p53 following disruption of the telomere. These telomere-initiated responses, in combination with UV-induced damage to critical regulatory genes, lead to the familiar picture of "photoaging." These and other insights into the molecular basis for skin aging/photoaging may lead to enhanced management options.


Assuntos
Envelhecimento da Pele/patologia , Pele/ultraestrutura , Telômero/fisiologia , Apoptose , Divisão Celular , Senescência Celular/fisiologia , DNA/efeitos da radiação , Dano ao DNA , Humanos , Estresse Oxidativo , Pele/efeitos da radiação , Luz Solar/efeitos adversos , Sequências de Repetição em Tandem , Telomerase/fisiologia , Telômero/ultraestrutura , Proteína 2 de Ligação a Repetições Teloméricas/fisiologia
10.
Hautarzt ; 53(3): 167-73, 2002 Mar.
Artigo em Alemão | MEDLINE | ID: mdl-11974587

RESUMO

There are at least two classic photoprotective DNA damage responses that can be elicited by UV exposure: induction of melanogenesis (tanning) and enhancement of DNA repair. Both mechanisms are mediated, at least in part, by the tumor-suppressor protein and transcription factor p53. Both of these responses can be induced in vitro as well as in vivo by small DNA fragments of specific sequences, without prior induction of actual DNA damage. The topical application of such fragments onto human skin might enhance photoprotection in human skin, as typically elicited by gradual sun exposure. The induction of photoprotection by this means, however, would not bear the mutagenic and carcinogenic risk of exposure to natural sunlight.


Assuntos
Dano ao DNA/efeitos da radiação , Reparo do DNA/efeitos da radiação , Oligonucleotídeos/metabolismo , Neoplasias Cutâneas/fisiopatologia , Queimadura Solar/fisiopatologia , Raios Ultravioleta/efeitos adversos , Animais , Dano ao DNA/fisiologia , Reparo do DNA/fisiologia , Expressão Gênica/fisiologia , Humanos , Oligonucleotídeos/farmacologia , Fatores de Risco , Neoplasias Cutâneas/prevenção & controle , Pigmentação da Pele/fisiologia , Pigmentação da Pele/efeitos da radiação , Queimadura Solar/prevenção & controle , Proteína Supressora de Tumor p53/genética
11.
Clin Exp Dermatol ; 26(7): 583-91, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11696062

RESUMO

An overview of keratinocyte and melanocyte function is provided. The processes of cutaneous ageing and photoageing are defined, and age-associated modulations in gene expression are described. The changes in keratinocytes and melanocytes that occur with skin ageing and photoageing and the characteristics of chronologically aged vs. photoaged skin are delineated. Mutations that are found in malignant and premalignant tumors of epidermal origin are described.


Assuntos
Queratinócitos/fisiologia , Melanócitos/fisiologia , Envelhecimento da Pele/fisiologia , Animais , Carcinoma Basocelular/genética , Carcinoma de Células Escamosas/genética , Divisão Celular/fisiologia , Feminino , Expressão Gênica , Cabelo/fisiologia , Humanos , Queratinócitos/citologia , Ceratose/etiologia , Masculino , Melanócitos/citologia , Melanoma/genética , Camundongos , Mutação/genética , Neoplasias Cutâneas/genética
12.
FASEB J ; 15(12): 2205-14, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11641247

RESUMO

During postnatal development, the hair follicle (HF) shows cyclic activity with periods of relative resting, active growth (anagen), and regression. We demonstrate that similar to the HF induction in embryonic skin, initiation of a new hair growth phase in postnatal skin requires neutralization of the inhibitory activity of bone morphogenetic protein 4 (BMP4) by the BMP antagonist noggin. In the resting HF, BMP4 mRNA predominates over noggin in the epithelium and mesenchyme, and the BMP receptor IA is prominently expressed in the follicular germ. Anagen development is accompanied by down-regulation of the BMP4 and increased noggin mRNA in the HF. Furthermore, administration of noggin protein induces new hair growth phase in postnatal telogen skin in vivo. In contrast, BMP4 induces selective arrest of anagen development in the non-tylotrich (secondary) HF. As a hair growth inducer, noggin increases Shh mRNA in the HF whereas BMP4 down-regulates Shh. This suggests that modulation of BMP4 signaling by noggin is essential for hair growth phase induction in postnatal skin and that the hair growth-inducing effect of noggin is mediated, at least in part, by Shh.


Assuntos
Folículo Piloso/crescimento & desenvolvimento , Proteínas/farmacologia , Animais , Proteína Morfogenética Óssea 4 , Receptores de Proteínas Morfogenéticas Ósseas Tipo I , Proteínas Morfogenéticas Ósseas/biossíntese , Proteínas Morfogenéticas Ósseas/genética , Proteínas Morfogenéticas Ósseas/farmacologia , Proteínas de Transporte , Regulação para Baixo , Feminino , Folículo Piloso/anatomia & histologia , Folículo Piloso/efeitos dos fármacos , Proteínas Hedgehog , Camundongos , Camundongos Endogâmicos C57BL , Modelos Biológicos , Biossíntese de Proteínas , Proteínas Serina-Treonina Quinases/biossíntese , Proteínas Serina-Treonina Quinases/genética , Proteínas/genética , RNA Mensageiro/biossíntese , Receptores de Fatores de Crescimento/biossíntese , Receptores de Fatores de Crescimento/genética , Transativadores/biossíntese , Transativadores/genética , Regulação para Cima
13.
Clin Geriatr Med ; 17(4): 617-30, v, 2001 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11535419

RESUMO

Aging is a complex process influenced by telomere shortening and damage to cellular DNA. New insights into age-associated decrements in DNA damage repair are reviewed. Age-associated gross, histologic, and functional cutaneous deficits are delineated. Different treatment options for aged skin are examined.


Assuntos
Envelhecimento da Pele/fisiologia , Antioxidantes/uso terapêutico , Dano ao DNA , Reparo do DNA , Dieta , Terapia de Reposição Hormonal , Humanos , Hidroxiácidos/uso terapêutico , Ceratolíticos/uso terapêutico , Envelhecimento da Pele/efeitos dos fármacos , Fumar/efeitos adversos , Protetores Solares/uso terapêutico , Tretinoína/uso terapêutico
14.
Exp Dermatol ; 10(4): 272-9, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11493316

RESUMO

Exposure of skin to solar irradiation generates reactive oxygen species that damage DNA, membranes, mitochondria and proteins. To protect against such damage, skin cells have evolved antioxidant enzymes including glutathione peroxidase (GSH-Px), copper and zinc-dependent superoxide dismutase (SOD1), the mitochondrial manganese-dependent superoxide dismutase (SOD2), and catalase. This report examines the effect of a single low or moderate dose exposure to solar-simulating combined UVB and UVA irradiation on the gene expression and activities of these antioxidant enzymes in cultured normal human fibroblasts. We find that both doses initially decrease GSH-Px, SOD2 and catalase activities, but within 5 days after irradiation the activities of the enzymes return to pre-irradiation level (catalase) or are induced slightly (SOD1, GSH-Px) or substantially (SOD2) above the basal level. For SOD1, SOD2 and catalase, the higher dose also detectably modulates the mRNA level of these enzymes. Our results indicate that the effects of a single physiologic solar simulated irradiation dose persist for at least several days and suggest that skin cells prepare for subsequent exposure to damaging irradiation by upregulating this antioxidant defense system, in particular the mitochondrial SOD2. Our findings are consistent with the existence of a broad-based SOS-like response in irradiated human skin.


Assuntos
Fibroblastos/enzimologia , Fibroblastos/efeitos da radiação , Expressão Gênica/efeitos da radiação , Oxirredutases/metabolismo , Pele/enzimologia , Pele/efeitos da radiação , Luz Solar , Catalase/metabolismo , Células Cultivadas , Glutationa Peroxidase/metabolismo , Humanos , Pele/citologia , Superóxido Dismutase/metabolismo , Superóxido Dismutase-1 , Raios Ultravioleta
15.
Am J Pathol ; 158(6): 1913-9, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11395365

RESUMO

p53 is a transcription factor mediating a variety of biological responses including apoptotic cell death. p53 was recently shown to control apoptosis in the hair follicle induced by ionizing radiation and chemotherapy, but its role in the apoptosis-driven physiological hair follicle regression (catagen) remains to be elucidated. Here, we show that p53 protein is strongly expressed and co-localized with apoptotic markers in the regressing hair follicle compartments during catagen. In contrast to wild-type mice, p53 knockout mice show significant retardation of catagen accompanied by significant decrease in the number of apoptotic cells in the hair matrix. Furthermore, p53 null hair follicles are characterized by alterations in the expression of markers that are encoded by p53 target genes and are implicated in the control of catagen (Bax, Bcl-2, insulin-like growth factor binding protein-3). These data suggest that p53 is involved in the control of apoptosis in the hair follicle during physiological regression and imply that p53 antagonists may be useful for the management of hair growth disorders characterized by premature entry into catagen, such as androgenetic alopecia, alopecia areata, and telogen effluvium.


Assuntos
Apoptose , Folículo Piloso/citologia , Proteína Supressora de Tumor p53/fisiologia , Animais , Regulação para Baixo , Feminino , Folículo Piloso/metabolismo , Proteína 3 de Ligação a Fator de Crescimento Semelhante à Insulina/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Proteínas Proto-Oncogênicas/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Proteína Supressora de Tumor p53/genética , Regulação para Cima , Proteína X Associada a bcl-2
17.
FASEB J ; 15(3): 645-58, 2001 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11259383

RESUMO

Hair graying, an age-associated process of unknown etiology, is characterized by a reduced number and activity of hair follicle (HF) melanocytes. Stem cell factor (SCF) and its receptor c-kit are important for melanocyte survival during development, and mutations in these genes result in unpigmented hairs. Here we show that during cyclic HF regeneration in C57BL/6 mice, proliferating, differentiating, and melanin-producing melanocytes express c-kit, whereas presumptive melanocyte precursors do not. SCF overexpression in HF epithelium significantly increases the number and proliferative activity of melanocytes. During the induced hair cycle in C57BL/6 mice, administration of anti-c-kit antibody dose-dependently decreases hair pigmentation and leads to partially depigmented (gray) or fully depigmented (white) hairs, associated with significant decreases in melanocyte proliferation and differentiation, as determined by immunostaining and confocal microscopy. However, in the next hair cycle, the previously treated animals grow fully pigmented hairs with the normal number and distribution of melanocytes. This suggests that melanocyte stem cells are not dependent on SCF/c-kit and when appropriately stimulated can generate melanogenically active melanocytes. Therefore, the blockade of c-kit signaling offers a fully reversible model for hair depigmentation, which might be used for the studies of hair pigmentation disorders.


Assuntos
Cor de Cabelo/fisiologia , Folículo Piloso/fisiologia , Melanócitos/fisiologia , Glicoproteínas de Membrana , Oxirredutases , Proteínas/metabolismo , Proteínas Proto-Oncogênicas c-kit/metabolismo , Transdução de Sinais , Fator de Células-Tronco/metabolismo , Animais , Anticorpos Monoclonais/metabolismo , Anticorpos Monoclonais/farmacologia , Células Epidérmicas , Epiderme/metabolismo , Feminino , Folículo Piloso/anatomia & histologia , Folículo Piloso/efeitos dos fármacos , Humanos , Imuno-Histoquímica , Marcação In Situ das Extremidades Cortadas , Antígeno Ki-67/genética , Antígeno Ki-67/metabolismo , Melanócitos/citologia , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Microscopia Confocal , Proteínas/genética , Proteínas Proto-Oncogênicas c-kit/genética
18.
J Dermatol Sci ; 25(2): 127-38, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11164709

RESUMO

It has been shown that the small DNA fragment thymidine dinucleotide, (pTpT) induces photoprotective responses in cultured cells and intact skin. These responses include increased melanogenesis, enhanced DNA repair, and induction of TNF-alpha, and are accomplished, at least in part, through the induction and activation of the p53 tumor suppressor and transcription factor. Here it is reported that other, but not all, larger oligonucleotides induce the pigmentation response even more efficiently than pTpT. A 9 base oligonucleotide (p9mer) stimulated pigmentation in Cloudman S91 murine melanoma cells to 6-times the level of control cells while a 5 base oligonucleotide (p5mer#1) was inactive. In addition, the p9mer increased p21 mRNA levels and inhibited cell proliferation to a greater degree than did pTpT, consistent with the presumptive mechanism of action involving p53. Smaller, truncated versions of the p9mer also stimulated pigmentation, although to a lesser extent than did the p9mer. The ability of these oligonucleotides to stimulate pigmentation was highly dependent on the presence of a 5' phosphate group on the molecule, which was shown by confocal microscopy and fluorescent activated cell sorter (FACS) analysis to greatly facilitate the uptake of these oligonucleotides into the cells. Although the melanogenic activity of the oligonucleotides was directly related to increased length and 5' phosphorylation, nucleotide sequence is also critical because a p20mer was efficiently internalized yet was a poor inducer of pigmentation.


Assuntos
DNA/genética , Melaninas/biossíntese , Oligonucleotídeos/farmacologia , Animais , Sequência de Bases , Camundongos , Oligonucleotídeos/química , Oligonucleotídeos/metabolismo , Oligonucleotídeos/farmacocinética , Fosforilação , Nucleotídeos de Timina/química , Nucleotídeos de Timina/metabolismo , Nucleotídeos de Timina/farmacologia , Células Tumorais Cultivadas , Proteína Supressora de Tumor p53/fisiologia
20.
Curr Opin Oncol ; 13(2): 129-36, 2001 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11224711

RESUMO

Melanoma is the most common fatal malignancy among young adults, and its incidence and mortality continue to increase at an alarming rate. Epidemiologic studies have clearly demonstrated roles for genetic predisposition and sun exposure in melanoma development. In the past few years, substantial information has been added to the body of evidence suggesting that inherited and somatic genetic events contribute to the pathogenesis of melanoma. This review focuses on recent advances in the understanding of the genetic events, particularly aberration of cell cycle control and transcriptional control mechanisms, implicated in the pathogenesis of melanoma.


Assuntos
Melanoma/genética , Neoplasias Cutâneas/genética , Genes Supressores de Tumor/fisiologia , Humanos , Melanoma/epidemiologia , Melanoma/patologia , Proto-Oncogenes/fisiologia , Neoplasias Cutâneas/epidemiologia , Neoplasias Cutâneas/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...